Vermont § 4257 - Prevention and treatment of opioid-related overdoses

§ 4257. Prevention and treatment of opioid-related overdoses

• (a) As used in this section: (1) “Health care professional” means a physician licensed pursuant to 26 V.S.A. chapter
  23 or 33, a physician assistant licensed to prescribe and dispense prescription drugs
  pursuant to 26 V.S.A. chapter 31, an advanced practice registered nurse authorized
  to prescribe and dispense prescription drugs pursuant to 26 V.S.A. chapter 28, or
  a pharmacist licensed pursuant to 26 V.S.A. chapter 36. (2) “Opioid antagonist” means a drug that, when administered, negates or neutralizes in
  whole or part the pharmacological effects of an opioid in the body. (3) “Victim” means the person who has overdosed on an opioid or who is believed to have
  overdosed on an opioid. (b) For the purpose of addressing prescription and nonprescription opioid overdoses in
  Vermont, the Department shall develop and implement a prevention, intervention, and
  response strategy, depending on available resources, that shall: (1) provide educational materials on opioid overdose prevention to the public free of
  charge; (2) increase community-based prevention programs aimed at reducing risk factors that lead
  to opioid overdoses; (3) increase timely access to treatment services for opioid users, including medication
  for opioid use disorder; (4)(A) educate substance use treatment providers on methods to prevent opioid overdoses; (B) provide education, information, and training on overdose prevention, intervention,
  and response, including the status of legal possession of substances and harm reduction
  supplies, to individuals living with opioid use disorder and participating in needle
  and syringe exchange programs, recovery programs, residential substance use disorder
  treatment programs, or correctional services; (5) implement and expand hospital referral services for individuals treated for an opioid
  overdose; (6) develop a statewide opioid antagonist program that emphasizes access to opioid antagonists
  to and for the benefit of individuals with opioid use disorder; (7) distribute opioid antagonists to assist those at risk of experiencing an opioid-related
  overdose; and (8) establish opioid antagonist dispensing kiosks in locations accessible to those at
  risk of experiencing an opioid-related overdose. (c)(1) A health care professional acting in good faith and within the professional’s scope
  of practice may directly or by standing order prescribe, dispense, and distribute
  an opioid antagonist to the following persons: (A) a person at risk of experiencing an opioid-related overdose; or (B) a family member, friend, or other person in a position to assist a person at risk
  of experiencing an opioid-related overdose. (2) A health care professional who prescribes, dispenses, or distributes an opioid antagonist
  in accordance with subdivision (1) of this subsection shall be immune from civil or
  criminal liability with regard to the subsequent use of the opioid antagonist, unless
  the health professional’s actions with regard to prescribing, dispensing, or distributing
  the opioid antagonist constituted recklessness, gross negligence, or intentional misconduct.
  The immunity granted in this subdivision shall apply whether or not the opioid antagonist
  is administered by or to a person other than the person for whom it was prescribed. (d)(1) A person may administer an opioid antagonist to a victim if the person believes, in
  good faith, that the victim is experiencing an opioid-related overdose. (2) A person shall be immune from civil or criminal liability for administering an opioid
  antagonist to a victim pursuant to subdivision (1) of this subsection unless the person’s
  actions constituted recklessness, gross negligence, or intentional misconduct. The
  immunity granted in this subdivision shall apply whether or not the opioid antagonist
  is administered by or to a person other than the person for whom it was prescribed. (e) A person acting on behalf of a community-based overdose prevention program or a licensed
  pharmacist shall be immune from civil or criminal liability for providing education
  on opioid-related overdose prevention or for purchasing, acquiring, distributing,
  or possessing an opioid antagonist unless the person’s actions constituted recklessness,
  gross negligence, or intentional misconduct. (f) Any health care professional who treats a victim and who has knowledge that the victim
  has been administered an opioid antagonist within the preceding 30 days shall refer
  the victim to professional substance use disorder treatment services. (Added 2013, No. 75, § 17; amended 2015, No. 38, § 25, eff. May 28, 2015; 2023, No. 22, § 4, eff. May 25, 2023; renumbered from 18 V.S.A. § 4240 by 2023, No. 178 (Adj. Sess.), § 8, eff. June 17, 2024.)